Specialty Pharmaceutical Management
• Specialty pharmaceuticals are considered to be
high-cost injectable, infused, oral or inhaled biotech medications that
require patient monitoring and professional support.
• These pharmaceutical are expensive and historically
fall outside of traditional cost containment initiatives. Specialty
pharmacy represents 25% of total Medicaid pharmacy spend and industry
forecasts show that specialty pharmacy could grow to 50% of pharmacy
spend by 2014.
• Wisconsin Medicaid will pursue increased controls
and monitoring of these expensive biologic drugs by reviewing where
these drugs are administered, implementing utilization controls, and
achieving discounts through preferred purchasing methodologies.
Specialty Pharmaceutical Management (PDF,
60 KB)
Provide
Input on Specialty Pharmaceutical Management
PDF: The free Adobe Reader® software is
needed to view and print portable document format (PDF) files. Learn
more.
Last Revised: September 30, 2011 |
